|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.220 USD | +3.26% |
|
+17.77% | -58.66% |
Company Valuation: Compass Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 309 | 633.5 | 198.8 | 199.5 | 955.1 | 399.8 | - | - |
| Change | - | 105.02% | -68.61% | 0.34% | 378.75% | -58.14% | - | - |
| Enterprise Value (EV) 1 | 309 | 633.5 | 198.8 | 72.78 | 955.1 | 249.8 | 266.8 | 283.8 |
| Change | - | 105.02% | -68.61% | -63.39% | 1,212.3% | -73.85% | 6.81% | 6.37% |
| P/E | -2.42x | -13.6x | -4.73x | -4.03x | -12.8x | -4.54x | -4.47x | -13.4x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.2x | 0.4x | -0.44x | -0.8x | -0.3x | -2.76x | 0.2x |
| Capitalization / Revenue | - | - | - | 235x | - | - | 14.4x | 3.07x |
| EV / Revenue | - | - | - | 85.6x | - | - | 9.63x | 2.18x |
| EV / EBITDA | -3.8x | -15.5x | -4x | -1.3x | -13.2x | -2.49x | -2.49x | -2.76x |
| EV / EBIT | -3.77x | -15.2x | -3.95x | -1.29x | -13.1x | -2.61x | -2.64x | -7.62x |
| EV / FCF | -14.3x | - | - | -1.62x | -19.4x | -3.49x | -3.41x | -14.7x |
| FCF Yield | -6.98% | - | - | -61.7% | -5.15% | -28.7% | -29.3% | -6.81% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.31 | -0.37 | -0.33 | -0.36 | -0.42 | -0.4892 | -0.4971 | -0.1662 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | 0.85 | - | - | 27.7 | 130.3 |
| EBITDA 1 | -81.32 | -40.87 | -49.66 | -56.04 | -72.56 | -100.2 | -107 | -102.6 |
| EBIT 1 | -81.88 | -41.66 | -50.36 | -56.62 | -72.84 | -95.65 | -100.9 | -37.27 |
| Net income 1 | -82.18 | -39.22 | -42.49 | -49.38 | -66.49 | -93.05 | -99.91 | -34.9 |
| Net Debt 1 | - | - | - | -126.7 | - | -150 | -133 | -116 |
| Reference price 2 | 3.170 | 5.030 | 1.560 | 1.450 | 5.370 | 2.220 | 2.220 | 2.220 |
| Nbr of stocks (in thousands) | 97,472 | 125,938 | 127,455 | 137,589 | 177,862 | 180,088 | - | - |
| Announcement Date | 18/03/22 | 15/03/23 | 21/03/24 | 27/02/25 | 05/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.54x | - | -2.49x | - | 400M | |
| 21.3x | 7.43x | 15.26x | 1.36% | 70.85B | |
| 31.57x | 8.07x | 24.56x | 0.05% | 55.41B | |
| -88.15x | 15.96x | -81.34x | -.--% | 29.43B | |
| 30.62x | 6x | 15.89x | -.--% | 24.12B | |
| -14.59x | 5.14x | -6.7x | -.--% | 23.31B | |
| 25.2x | 4.79x | 16.23x | -.--% | 18.37B | |
| 51.07x | 20.81x | 53.59x | 0.07% | 16.99B | |
| -1224.8x | 38.15x | -15185.1x | -.--% | 16.1B | |
| 16.43x | 4.85x | 11.32x | -.--% | 13.12B | |
| Average | -115.59x | 12.36x | -1,513.88x | 0.16% | 26.81B | |
| Weighted average by Cap. | -63.83x | 10.56x | -905.85x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CMPX Stock
- Valuation Compass Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
